Back to Journals » Open Access Journal of Clinical Trials » Volume 12
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Remdesivir is Effective for Moderately Severe Patients: A Re-Analysis of the First Double-Blind, Placebo-Controlled, Randomized Trial on Remdesivir for Treatment of Severe COVID-19 Patients Conducted in Wuhan City
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,017 | Dovepress* | 8,017+ | 1,018 | 9,035 | |
Totals | 8,017 | 1,018 | 9,035 | ||
*Since 30 July 2020 |
View citations on Google Scholar